PEPG (STOCKS)
PepGen Inc. Common Stock
$1.690000
+0.050000 (+3.05%)
Prev close: $1.640000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- James Gregg McArthur
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $117.50M
- Employees
- 62
- P/E (TTM)
- -0.70
- P/B (TTM)
- 0.77
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $4.01M |
| Operating Expenses | $93.61M |
| Research and Development | $71.04M |
| Other Operating Expenses | $22.57M |
| Operating Income/Loss | -$93.61M |
| Income/Loss From Continuing Operations After Tax | -$89.66M |
| Income/Loss From Continuing Operations Before Tax | -$89.61M |
| Income Tax Expense/Benefit | $49.00K |
| Income Tax Expense/Benefit, Current | $49.00K |
| Net Income/Loss | -$89.66M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$89.66M |
| Net Income/Loss Available To Common Stockholders, Basic | -$89.66M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.12 |
| Diluted Earnings Per Share | -$2.12 |
| Basic Average Shares | 42,221,808 |
| Diluted Average Shares | 42,221,808 |
| Assets | $173.91M |
| Current Assets | $150.96M |
| Cash | $148.50M |
| Other Current Assets | $2.46M |
| Noncurrent Assets | $22.94M |
| Fixed Assets | $1.90M |
| Other Non-current Assets | $21.04M |
| Liabilities | $26.46M |
| Current Liabilities | $12.65M |
| Accounts Payable | $822.00K |
| Wages | $4.66M |
| Other Current Liabilities | $7.16M |
| Noncurrent Liabilities | $13.82M |
| Equity | $147.44M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $147.44M |
| Liabilities And Equity | $173.91M |
| Net Cash Flow From Operating Activities | -$81.64M |
| Net Cash Flow From Operating Activities, Continuing | -$81.64M |
| Net Cash Flow From Investing Activities | -$15.24M |
| Net Cash Flow From Investing Activities, Continuing | -$15.24M |
| Net Cash Flow From Financing Activities | $107.98M |
| Net Cash Flow From Financing Activities, Continuing | $107.98M |
| Net Cash Flow | $11.11M |
| Net Cash Flow, Continuing | $11.11M |
| Comprehensive Income/Loss | -$89.67M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$89.67M |
| Other Comprehensive Income/Loss | -$89.67M |